Design-of-experiment approach for determination of fat soluble vitamins on core-shell technology stationary phase by PHLC / Norhan Ahmed Shokry Elgizawy ; Supervised Rasha Sayed Hanafi
Material type:
TextLanguage: English Publication details: Cairo : Norhan Ahmed Shokry Elgizawy , 2015Description: 125 Leaves : photographs ; 30cmSubject(s): Dissertation note: Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceulical Chemistry Summary: Through the last decades, fat-soluble vitamins (FSV) analysis has been tremendously apptoached. A lot of HPLC methods have been reported with a variety of pros and cons, yet, these reports did not define the design space of HPLC analysis of these vitamins, although the design space of water-soluble vitamins has been defined. According to the food and drug administration (FDA), applying the quality by design principle for the analysis of commercially available mixtures will facilitate the process of approvals by regulatory bodies, and accordingly will enhance the pharnaceutical industry
| Item type | Current library | Home library | Call number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
Thesis
|
قاعة الثقاقات الاجنبية - الدور الثالث | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.34.M.Sc.2015.No.D (Browse shelf(Opens below)) | Not for loan | 01010110072295000 |
Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceulical Chemistry
Through the last decades, fat-soluble vitamins (FSV) analysis has been tremendously apptoached. A lot of HPLC methods have been reported with a variety of pros and cons, yet, these reports did not define the design space of HPLC analysis of these vitamins, although the design space of water-soluble vitamins has been defined. According to the food and drug administration (FDA), applying the quality by design principle for the analysis of commercially available mixtures will facilitate the process of approvals by regulatory bodies, and accordingly will enhance the pharnaceutical industry
There are no comments on this title.